Mitigating and eradicating central line-associated bloodstream infections (CLABSI) is a vital patient safety priority. These healthcare-associated infections lead to patient fatalities and incur costly, preventable expenses. Therefore, it is imperative to assess central venous catheter (CVC) maintenance protocols to mitigate the likelihood of infection. Federal guidelines advocate using chlorhexidine (CHG) dressings to lower this risk (Centers for Disease Control and Prevention, 2017). A comprehensive central line maintenance bundle includes incorporating a CHG dressing as a critical measure in reducing the risk of CLABSI (Buetti et al., 2022). Consequently, the escalating infection rates underscore the necessity for implementing CHG dressings (Buetti et al., 2022).

Currently, two CHG-based CVC dressings, namely the CHG gel and disk dressings, are commercially accessible. This project aims to deploy CHG gel dressings for patients necessitating CVCs admitted to units with a documented history of elevated rates of CLABSI. The anticipated outcome of introducing the CHG gel dressings is reducing CLABSI incidence rates. This project aims to show this distinct reduction in CLABSI rates in a twelve-week time frame. This intervention presents a straightforward yet highly efficient solution with the anticipated outcome of reducing the incidence of CLABSIs.

Date of publication

Spring 4-20-2024

Document Type

MSN Capstone Project



Persistent identifier



Master of Science in Nursing Administration